Posted on 20 December 2012.
Supreme Court of Canada Upholds Standard of Disclosure
Teva Canada sought an NOC to market a generic version of sildenafil, alleging that the patent was invalid on various grounds, namely, obviousness, lack of utility and insufficiency of disclosure. These allegations were successfully denied by Pfizer …
Full News here – Read more on Blakes